Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q2 2026 · 10-Q
Revenue$551.68M$551.68M+0.5% vs Q2 2025 Net Income$19.09M$19.09M−46.0% vs Q2 2025 EPS Diluted$0.76$0.76−46.9% vs Q2 2025 Gross Profit$235,053,000+13.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$80,150,000+614.9% Free Cash Flowderived$61,639,000N/M Margins · derivedGross margin42.6%+4.7 pt vs Q2 2025
Operating margin7.1%+5.2 pt vs Q2 2025
Net margin3.5%−3.0 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end